(losses) on investments (asset management and strategic holdings) of $1.0 billion and $0.8 billion during the three months ended March 31, 2025 and 2024, respectively, (iv) capital allocation-based income (loss) (asset management and strategic holdings) of $1.2 billion and  $1.3 billion during the three months ended March 31, 2025 and 2024, respectively, (v) net investment and policy liability-related gains (losses) (insurance) of $(1.7) billion and $(0.6) billion during the three months ended March 31, 2025 and 2024, respectively, and (vi) interest credited to policyholder account balances (net of policy fees) (insurance) of $1.2 billion and $0.9 billion during the three months ended March 31, 2025 and 2024, respectively. Investment funds are investment companies under GAAP and reflect their investments and other financial instruments at fair value.
Net Cash Provided (Used) by Investing Activities
Our net cash provided (used) by investing activities was $(3.1) billion and $(6.2) billion during the three months ended March 31, 2025 and 2024, respectively. Our investing activities primarily included: (i) investments purchased (insurance), net of proceeds from investments (insurance), of $(3.1) billion and $(6.2) billion during the three months ended March 31, 2025 and 2024, respectively, and (ii) the purchase of fixed assets of $(20.8) million and $(17.3) million during the three months ended March 31, 2025 and 2024, respectively.
Net Cash Provided (Used) by Financing Activities
Our net cash provided (used) by financing activities was $3.6 billion and $45.0 million during the three months ended March 31, 2025 and 2024, respectively. Our financing activities primarily included: (i) contributions from, net of distributions to, our noncontrolling and redeemable noncontrolling interests of $0.2 billion and $(23.8) million during the three months ended March 31, 2025 and 2024, respectively, (ii) proceeds received, net of repayment of debt obligations, of $(0.5) billion and $0.8 billion during the three months ended March 31, 2025 and 2024, respectively, (iii) proceeds from the issuance of Series D Mandatory Convertible Preferred Stock (net of issuance cost) of $2.5 billion during the three months ended March 31, 2025, (iv) additions to, net of withdrawals from, contractholder deposit funds (insurance) of $1.5 billion and $2.6 billion during the three months ended March 31, 2025 and 2024, respectively, (v) reinsurance transactions, net of cash provided (insurance) of $12.2 million during the three months ended March 31, 2024, and (vi) common stock dividends of $(155.4) million and $(146.0) million during the three months ended March 31, 2025 and 2024, respectively.
127
Table of
Contents
Analysis of Segment Operating Results
The following is a discussion of the results of our business on a segment basis for the three months ended March 31, 2025 and 2024. You should read this discussion in conjunction with the information included under "—Analysis of Non-